Is XENT or EQR a better dividend investment in 2026?

XENT currently yields 7.08% with a 5% 5-year dividend growth rate. EQR yields 4.73% with 5% growth. The better choice depends on your goal: XENT offers higher current income.

What is the dividend yield difference between XENT and EQR?

XENT has a forward dividend yield of 7.08% ($2.00/share annually). EQR yields 4.73% ($2.77/share annually). The yield gap is 2.35 percentage points.

Home › Compare › XENT vs EQR

XENT vs EQR: Dividend Comparison 2026

XENT yields 7.08% · EQR yields 4.73%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EQR wins by $8.5K in total portfolio value· pulled ahead in Year 5

INVESTMENT

TIME HORIZON10 years

XENT

● Live price

7.08%

Share price

$28.24

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$32.0K

Annual income

$1,110.32

Full XENT calculator →

EQR

● Live price

4.73%

Share price

$58.58

Annual div

$2.77

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.5K

Annual income

$3,819.61

Full EQR calculator →

Portfolio growth — XENT vs EQR

📍 EQR pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XENT	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XENT + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XENT pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XENT

Annual income on $10K today (after 15% tax)

$601.98/yr

After 10yr DRIP, annual income (after tax)

$943.77/yr

EQR

Annual income on $10K today (after 15% tax)

$401.93/yr

After 10yr DRIP, annual income (after tax)

$3,246.67/yr

At 15% tax rate, EQR beats the other by $2,302.90/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XENT + EQR for your $10,000?

XENT: 50%EQR: 50%

100% EQR50/50100% XENT

Portfolio after 10yr

$36.2K

Annual income

$2,464.96/yr

Blended yield

6.81%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

XENT

No analyst data

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+20.1% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XENT buys

EQR buys

No recent congressional trades found for XENT or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXENTEQR

Forward yield	7.08% ✓	4.73%
Annual dividend / share	$2.00	$2.77 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$32.0K	$40.5K ✓
Annual income after 10y	$1,110.32	$3,819.61 ✓
Total dividends collected	$9.1K	$16.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: XENT vs EQR ($10,000, DRIP)

Year	XENT Portfolio	XENT Income/yr	EQR Portfolio	EQR Income/yr	Gap
1	$11,408	$708.22	$11,248	$547.57	+$160.00 → XENT
2	$12,962	$755.09	$12,701	$666.53	+$261.00 → XENT
3	$14,671	$801.80	$14,405	$814.59	+$266.00 → XENT
4	$16,546	$848.15	$16,413	$999.84	+$133.00 → XENT
5← crossover	$18,598	$893.98	$18,795	$1,232.92	$197.00 → EQR
6	$20,839	$939.12	$21,639	$1,527.95	$800.00 → EQR
7	$23,282	$983.44	$25,057	$1,903.80	$1.8K → EQR
8	$25,938	$1,026.81	$29,197	$2,385.87	$3.3K → EQR
9	$28,823	$1,069.13	$34,250	$3,008.70	$5.4K → EQR
10	$31,951	$1,110.32	$40,467	$3,819.61	$8.5K → EQR

XENT vs EQR: Complete Analysis 2026

XENT — Stock

Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.

Full XENT Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this XENT vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XENT vs SCHD XENT vs JEPI XENT vs O XENT vs KO XENT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.